These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23464850)

  • 21. Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?
    Jung JP; Zenati MS; Hamad A; Hogg ME; Simmons RL; Zureikat AH; Zeh HJ; Boone BA
    HPB (Oxford); 2019 Jun; 21(6):679-686. PubMed ID: 30501987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability.
    Cheung TT; Poon RT; Chok KS; Chan AC; Tsang SH; Dai WC; Chan SC; Fan ST; Lo CM
    World J Gastroenterol; 2014 Dec; 20(46):17448-55. PubMed ID: 25516657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
    Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical study about applying different R1 criteria to evaluate pancreatic head ductal adenocarcinoma specimens].
    Peng Y; Xiu D; Jiang B; Ma Z; Yuan C; Su J; Shi X; Li L; Tao M
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):834-8. PubMed ID: 25604022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
    Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
    Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
    Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?
    Lad NL; Squires MH; Maithel SK; Fisher SB; Mehta VV; Cardona K; Russell MC; Staley CA; Adsay NV; Kooby DA
    Ann Surg Oncol; 2013 Oct; 20(11):3626-33. PubMed ID: 23838908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
    Wang J; Estrella JS; Peng L; Rashid A; Varadhachary GR; Wang H; Lee JE; Pisters PW; Vauthey JN; Katz MH; Gomez HF; Evans DB; Abbruzzese JL; Fleming JB; Wang H
    Cancer; 2012 Aug; 118(15):3801-11. PubMed ID: 22180096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
    Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
    Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.
    Nakao A; Kanzaki A; Fujii T; Kodera Y; Yamada S; Sugimoto H; Nomoto S; Nakamura S; Morita S; Takeda S
    Ann Surg; 2012 Jan; 255(1):103-8. PubMed ID: 22156923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility.
    Pang TC; Wilson O; Argueta MA; Hugh TJ; Chou A; Samra JS; Gill AJ
    Pathology; 2014 Apr; 46(3):188-92. PubMed ID: 24614707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
    Shimoda M; Mori S; Kita J; Sawada T; Kubota K
    Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscopically positive (R1) resections do not affect survival in pancreatic head cancer.
    Mois E; Graur F; Al-Hajjar N; Zaharie F; Bartos A; Bodea R; Zaharie T; Rusu I; Iancu C
    Ann Ital Chir; 2017; 88():491-496. PubMed ID: 29339587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
    Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
    Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer.
    Kurihara C; Yoshimi F; Sasaki K; Nakao K; lijima T; Kawasaki H; Nagai H
    Hepatogastroenterology; 2013 Oct; 60(127):1759-65. PubMed ID: 24634947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological tumor invasion of the mesenterico-portal vein is characterized by aggressive biology and stromal fibroblast activation.
    Lapshyn H; Bolm L; Kohler I; Werner M; Billmann FG; Bausch D; Hopt UT; Makowiec F; Wittel UA; Keck T; Bronsert P; Wellner UF
    HPB (Oxford); 2017 Jan; 19(1):67-74. PubMed ID: 27825542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.